Sökning: "Progressive supranuclear palsy"
Visar resultat 1 - 5 av 11 avhandlingar innehållade orden Progressive supranuclear palsy.
1. The biology of cognitive decline and reduced survival in Parkinson disease : prognostic factors in a population-based cohort
Sammanfattning : Parkinson disease (PD) is a progressive neurodegenerative disease that affects about 1% of the population over 60 years. The cardinal symptoms are motor disabilities but cognitive decline is also common. About 50% of all persons with PD develop dementia within 10 years after disease onset. LÄS MER
2. Idiopathic parkinsonism : epidemiology and clinical characteristics of a population-based incidence cohort
Sammanfattning : Background: Idiopathic parkinsonism is a neurodegenerative syndrome of unknown cause and includes Parkinson’s disease (PD) and atypical parkinsonian disorders. The atypical parkinsonian disorders are: Multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). LÄS MER
3. Nuclear medicine methods in idiopathic Parkinsonism : pre- and postsynaptic dopamine SPECT
Sammanfattning : Background: Single photon emission computed tomography (SPECT) with dopamine transporter (DAT) and dopamine D2 receptor (D2R) ligands can visualise the integrity of the nigrostriatal dopamine system. Parkinson’s disease (PD) and the atypical parkinsonian diseases (APD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), have similar symptoms and dopamine depletion, but differ in pharmacological response and prognosis. LÄS MER
4. Magnetic Resonance Imaging in Parkinsons's disease and related disoders
Sammanfattning : Objectives: To identify diagnostic and prognostic biomarkers in the cerebral white (WM) and the deep grey matter (GM) in patients with Parkinson’s disease (PD) and atypical parkinsonian syndromes (APS) using magnetic resonance imaging (MRI). Methods: Patients with a clinical diagnosis of PD, multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) were included in the study. LÄS MER
5. Prognostic subtypes in Parkinson’s disease and related disorders. Clinical, genetical, and biochemical markers for long-term social, motor, and cognitive development
Sammanfattning : .... LÄS MER